Clinical Trial Update: Prednisone Timed-Release Tablet (TRT) Study: Modified-Release (MR) Formulation of Prednisone Compared to Standard Immediate-Release (IR) Prednisone in Participants With Rheumatoid Arthritis [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing a timed-release prednisone formulation to standard immediate-release prednisone in rheumatoid arthritis has completed and posted resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Prednisone Immediate-Release (prednisone)
• Prednisone Timed-Release Tablet (prednisone)

Snippet

Sponsor: Merck KGaA, Darmstadt, Germany | Conditions: Rheumatoid Arthritis | Phase 3 | Status: COMPLETED | Results posted: 2018-05-29